Rivaara Immune Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 18-01-2025
- Paid Up Capital ₹ 0.10 M
as on 18-01-2025
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -100.00%
(FY 2023)
- Profit -31.02%
(FY 2023)
- Ebitda -30.99%
(FY 2023)
- Net Worth -14.99%
(FY 2023)
- Total Assets 39.36%
(FY 2023)
About Rivaara Immune
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mayank Shah and Siddharth Daftary serve as directors at the Company.
- CIN/LLPIN
U85200MH2019PTC329805
- Company No.
329805
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rivaara Immune?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayank Shah  | Director | 05-Jan-2024 | Current |
| Siddharth Daftary | Director | 27-Aug-2019 | Current |
Financial Performance of Rivaara Immune.
Rivaara Immune Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 31.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rivaara Immune?
Unlock access to Rivaara Immune's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Arya Omnitalk Wireless Solutions Private LimitedActive 29 years 11 monthsMayank Shah is a mutual person
- Arya Omnitalk Radio Trunking Services Private LimitedActive 21 years 6 months
Mayank Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rivaara Immune?
Unlock and access historical data on people associated with Rivaara Immune, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rivaara Immune, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rivaara Immune's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
